Stay updated with breaking news from Breakthrough Indication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IceCure Medical Ltd. announced that the U.S. Food and Drug Administration has at this time denied the Company's De Novo Classification request for breast cancer which was submitted based on interim...
The FDA has denied IceCure Medical Ltd's (NASDAQ: ICCM) De Novo Classification request for the ProSense System for breast cancer, which was submitted based on interim
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...
A presentation during the Radiological Society of North America Scientific Session and Annual Meeting (RSNA 2022) featured IceCure Medical Ltd. and its minimally-invasive cryoablation technology, addressing Increasing interest among breast and interventional radiologists in performing breast tumor cryoablation.